gptkbp:instance_of
|
gptkb:biotechnology
|
gptkbp:acquisition
|
Neurimmune AG
|
gptkbp:clinical_trial
|
Completed
Ongoing
|
gptkbp:community_engagement
|
gptkb:activists
gptkb:collaboration
Health Education
|
gptkbp:employees
|
Approximately 1000
|
gptkbp:focus
|
Neurology
|
gptkbp:founded
|
gptkb:2003
|
gptkbp:headquarters
|
gptkb:Tokyo,_Japan
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biogen Idec Japan Ltd.
|
gptkbp:industry
|
Pharmaceuticals
|
gptkbp:market
|
gptkb:Japan
|
gptkbp:parent_company
|
gptkb:Biogen_Inc.
|
gptkbp:partnership
|
gptkb:Samsung_Bioepis
|
gptkbp:products
|
gptkb:Tecfidera
gptkb:Avonex
gptkb:Tysabri
|
gptkbp:regulatory_compliance
|
gptkb:Japan
|
gptkbp:research_focus
|
gptkb:muscular_dystrophy
gptkb:Multiple_Sclerosis
gptkb:neurodegenerative_diseases
|
gptkbp:services
|
gptkb:Research_and_Development
Commercialization
|
gptkbp:subsidiary
|
gptkb:Biogen_Idec_Inc.
|
gptkbp:sustainability_initiatives
|
gptkb:administration
Environmental Responsibility
Social Responsibility
|
gptkbp:website
|
www.biogen.com
|
gptkbp:bfsParent
|
gptkb:Biogen_Idec
|
gptkbp:bfsLayer
|
5
|